EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NIH Investment in HIV and Implementation Science

NIH-Investitionen in HIV und Implementierungsforschung

Geri R Donenberg, Daniel E Murphy, Amber Wilson, Robert C Cregg, Melissa Herrera, Mohini Bhakta, Hayatt Mohamed, Mary T Glenshaw iD

Journal of the International AIDS Society · 2026-10 · 29 (S5)

DOI: 10.1002/jia2.70148 ↗

Auf einen Blick

Die NIH finanzierten von FY2021–2024 Forschung an der Schnittstelle von HIV und Dissemination and Implementation Research. Die Investitionen stiegen, blieben aber 2024 mit 7% des HIV-Budgets ein kleiner Anteil.

Fragestellung

Wie viel hat das NIH in den Jahren FY2021–2024 in HIV-bezogene Implementierungsforschung investiert?

Methode

Portfolioanalyse des NIH Office of AIDS Research mit IMPAC II, RCDC und manueller Kodierung; Auswertung von Awards mit HIV und Dissemination and Implementation Research (D&IR) aus FY2021–2024, mit Detailanalyse von FY2024.

Ergebnisse

Das NIH investierte USD 697 million in 1569 Awards. In FY24 gab es 407 Awards; das entsprach 7% des gesamten vom Kongress bewilligten NIH-HIV-Budgets. 15 NIH institutes, centres and offices waren beteiligt.

Einschränkungen

Charakterisierung der Awards zu wichtigen Implementierungsfaktoren war nur eingeschränkt möglich.

Schlussfolgerung der Autor:innen

Die NIH-Investitionen in HIV-bezogene Implementierungsforschung wachsen, machten 2024 aber nur einen kleinen Teil des HIV-Budgets aus. Die Daten zeigen Bedarf, die Forschung weiter zu stärken, um HIV zu beenden und den öffentlichen Gesundheitseffekt zu sichern.

Kernaussagen

  • FY2021–2024: USD 697 million in 1569 Awards
  • FY24: 407 Awards, 7% des NIH-HIV-Budgets
  • CFIR häufig genannt; >93% mit quantitativen und qualitativen Methoden

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the International AIDS Society, online erschienen am 08.10.2026. Verfasst von Geri R Donenberg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Office of AIDS Research, National Institutes of Health, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: National Institutes of Health (U.S.), HIV Infections, Implementation Science, Biomedical Research. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Research supported by the National Institutes of Health (NIH) has revolutionized HIV prevention and treatment, but not all people have benefited from these advancements. Implementation science seeks to bridge the gap between a discovery and when it is applied in the real world, by elucidating the methods that promote the adoption, uptake and integration of evidence‐based strategies into routine care. Disparities in who benefits from the advancements have prompted calls to accelerate HIV implementation science. This paper provides a snapshot of research funded by the NIH at the intersection of HIV and implementation science.

Methods

The NIH Office of AIDS Research conducted portfolio analyses using the Information for Management Planning Analysis and Coordination (IMPAC II) database; the Research, Condition, and Disease Categorization (RCDC) system; and manual coding to describe select award characteristics. We examined awards coded as both RCDC categories HIV and Dissemination and Implementation Research (D&IR) from fiscal years (FY) 2021–2024, followed by more detailed analyses of awards made in FY2024.

Results

NIH invested USD 697 million in 1569 awards at the intersection of HIV and D&IR from FY2021–2024. During this period, funding for D&IR and HIV increased by 65%. In FY24 alone, 407 awards were made in D&IR and HIV, representing 7% of the total NIH HIV budget appropriated by Congress. Led by the National Institute of Mental Health, support for D&IR in HIV was represented by 15 NIH institutes, centres and offices. Among a subset of 226 FY24 awards consisting of R‐mechanisms, studies spanned the HIV prevention and treatment cascade and focused on multiple age groups. Forty‐one percent of the awards included hybrid effectiveness‐implementation designs, and the Consolidated Framework for Implementation Research (CFIR) was the most frequently cited framework ( n = 82; 37%). Over 93% of awards employed both quantitative and qualitative methods.

Conclusions

The NIH investment in HIV‐related implementation science is growing, but it made up a small portion (7%) of the total HIV budget in FY24. Challenges characterizing awards on key implementation science factors underscore opportunities to strengthen the science. These data support NIH's commitment to accelerate implementation research to end HIV and ensure its full public health benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

National Institutes of Health (U.S.)HIV InfectionsImplementation ScienceBiomedical ResearchHumansUnited States

Stichwörter der Autor:innen

HIVNIHimplementation scienceportfolio analysisresearch supportstrategic planning

Autor:innen und Institutionen

  • Office of AIDS Research, National Institutes of Health, Rockville, Maryland, USA.

ORCID-Profile: Mary T Glenshaw

Zitieren

APA

Donenberg, G. R., Murphy, D. E., Wilson, A., Cregg, R. C., Herrera, M., Bhakta, M., Mohamed, H., & Glenshaw, M. T. (2026). NIH Investment in HIV and Implementation Science. Journal of the International AIDS Society, 29(S5). https://doi.org/10.1002/jia2.70148

Vancouver

Donenberg GR, Murphy DE, Wilson A, Cregg RC, Herrera M, Bhakta M, et al. NIH Investment in HIV and Implementation Science. Journal of the International AIDS Society. 2026;29(S5). doi:10.1002/jia2.70148

BibTeX
@article{Donenberg2026,
  author = {Donenberg, Geri R and Murphy, Daniel E and Wilson, Amber and Cregg, Robert C and Herrera, Melissa and Bhakta, Mohini and Mohamed, Hayatt and Glenshaw, Mary T},
  title = {NIH Investment in HIV and Implementation Science},
  journal = {Journal of the International AIDS Society},
  year = {2026},
  volume = {29},
  number = {S5},
  doi = {10.1002/jia2.70148}
}
Kostenlos starten →